Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05745805 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China

StatusUnknown
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 27, 2023 (before its estimated June 12, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Feb 2023); last known: Recruiting
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.
Trial Details
NCT Number NCT05745805
Lead Sponsor First Affiliated Hospital Xi'an Jiaotong University
Collaborators: Nuclear 215 Hospital of Shaanxi Province, Yanan Traditional Chinese Medicine Hospital, Shangluo Central Hospital, Xian QinHuang Hospital, Yulin No.2 Hospital, Hanzhong Central Hospital, Ankang Central Hospital, Baoji High-tech Hospital
Conditions
(from sponsor)		 COVID-19, Post-COVID-19 Syndrome, Acute COVID-19, Post-Acute COVID-19
Related terms COVID-19, Post-Acute COVID-19 Syndrome
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov